- Home
- PRAX vs UP Comparison
PRAX vs UP Comparison
Compare PRAX & UP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- UP
- Stock Information
- Founded
- PRAX 2015
- UP 2013
- Country
- PRAX United States
- UP United States
- Employees
- PRAX N/A
- UP N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- UP Aerospace
- Sector
- PRAX Health Care
- UP Consumer Discretionary
- Exchange
- PRAX Nasdaq
- UP Nasdaq
- Market Cap
- PRAX 950.8M
- UP 1.0B
- IPO Year
- PRAX 2020
- UP N/A
- Fundamental
- Price
- PRAX $46.85
- UP $2.14
- Analyst Decision
- PRAX Strong Buy
- UP
- Analyst Count
- PRAX 9
- UP 0
- Target Price
- PRAX $94.44
- UP N/A
- AVG Volume (30 Days)
- PRAX 388.4K
- UP 9.3M
- Earning Date
- PRAX 08-04-2025
- UP 08-07-2025
- Dividend Yield
- PRAX N/A
- UP N/A
- EPS Growth
- PRAX N/A
- UP N/A
- EPS
- PRAX N/A
- UP N/A
- Revenue
- PRAX $7,765,000.00
- UP $765,885,000.00
- Revenue This Year
- PRAX N/A
- UP $174.46
- Revenue Next Year
- PRAX $25.00
- UP N/A
- P/E Ratio
- PRAX N/A
- UP N/A
- Revenue Growth
- PRAX 338.45
- UP N/A
- 52 Week Low
- PRAX $26.70
- UP $0.74
- 52 Week High
- PRAX $91.83
- UP $3.50
- Technical
- Relative Strength Index (RSI)
- PRAX 47.63
- UP 50.83
- Support Level
- PRAX $44.13
- UP $2.21
- Resistance Level
- PRAX $47.06
- UP $2.69
- Average True Range (ATR)
- PRAX 2.18
- UP 0.44
- MACD
- PRAX 0.05
- UP -0.02
- Stochastic Oscillator
- PRAX 54.73
- UP 27.01
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About UP Wheels Up Experience Inc.
Wheels Up Experience Inc is a provider of on-demand private aviation in the United States. It is pioneering data and technology-driven solutions that connect consumers to safety-vetted and verified private aircraft. It connects private flyers to aircraft, and one another, through an open platform that enables life's most important experiences. Its offering is delivered through a mix of programmatic and charter options that strategically utilize its owned and leased aircraft fleet and an "asset-light" charter model to deliver a greater range of global travel alternatives. The company operates in a single operating and reportable segment, private aviation services. Geographically the company generates the majority of its revenue from the United States.